C82.0

Clinical Causes: The exact cause of follicular lymphoma is unknown, but it involves genetic mutations that lead to abnormal growth of lymphocytes. Certain genetic factors may increase the risk, including specific gene rearrangements. Environmental exposures such as chemicals or radiation are considered potential but unconfirmed risk factors. Age is a significant factor, with most cases diagnosed in individuals over 60. A weakened immune system could contribute to the development of lymphomas.

Key Symptoms: Painless swelling of lymph nodes, typically in the neck, armpits, or groin. Fatigue or a general feeling of tiredness. Unexplained weight loss. Fever without an infection. Night sweats. Persistent or recurring infections.

Diagnosis Path: Diagnosis usually involves a combination of physical examinations, blood tests, imaging scans like CT or PET scans, and a biopsy of affected lymph node tissue. Pathological analysis confirms the presence of follicular lymphoma cells, and grading determines the disease's aggressiveness. Grade I indicates the lowest grade, signifying slow growth.

Treatment Protocols: Treatment strategies for follicular lymphoma grade I often focus on monitoring and when necessary, intervention. Options include: - **Watchful Waiting:** Close observation without immediate treatment, especially if the disease is not causing symptoms. - **Radiation Therapy:** Targeted radiation may be used for localized tumors. - **Immunotherapy:** Using medications that help the body's immune system recognize and attack cancer cells. - **Chemotherapy:** Medications administered to destroy cancerous cells in more advanced or symptomatic cases. - **Targeted Therapy:** Drugs that specifically attack cancer cell mechanisms. The choice of treatment depends on factors like disease progression, symptoms, overall health, and patient preferences.